Search Results

Filter
  • 1-10 of  56,864 results for ""DESIGNER drugs""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

How 3D printing technologies could undermine law enforcement strategies targeting the production and distribution of designer drugs.

  • Authors : Gilpin V; School of Engineering, Ulster University, Belfast, Northern Ireland BT15 1ED, UK.; Smith RB

Subjects: Printing, Three-Dimensional* ; Fentanyl* ; Designer Drugs*

  • Source: Science & justice : journal of the Forensic Science Society [Sci Justice] 2024 Nov; Vol. 64 (6), pp. 677-687. Date of Electronic Publication: 2024 Oct 28.Publisher: Elsevier Country of Publication: England NLM ID: 9508563 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1876-4452

Record details

×
Academic Journal

Metabolism and detection of designer benzodiazepines: a systematic review.

  • Authors : Gameli PS; Department of Biomedical Sciences and Public Health, Marche Polytechnic University, Ancona, Italy.; Huestis MA

Subjects: Benzodiazepines*/Benzodiazepines*/Benzodiazepines*/metabolism ; Benzodiazepines*/Benzodiazepines*/Benzodiazepines*/pharmacokinetics ; Benzodiazepines*/Benzodiazepines*/Benzodiazepines*/chemistry

  • Source: Drug metabolism reviews [Drug Metab Rev] 2024 Nov; Vol. 56 (4), pp. 359-384. Date of Electronic Publication: 2024 Oct 14.Publisher: Informa Healthcare Country of Publication: England NLM ID: 0322067 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Editorial & Opinion

Designer drugs.

Subjects: Designer Drugs*/Designer Drugs*/Designer Drugs*/adverse effects; Humans

  • Source: Laboratory medicine [Lab Med] 2023 Nov 02; Vol. 54 (6), pp. 553-554.Publisher: Oxford University Press Country of Publication: England NLM ID: 0250641 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Size-reduced DREADD derivatives for AAV-assisted multimodal chemogenetic control of neuronal activity and behavior.

  • Authors : Miyake T; Department of Systems Biology, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyō-ku, Kyoto 606-8501, Japan. Electronic address: .; Tanaka K

Subjects: Dependovirus*/Dependovirus*/Dependovirus*/genetics ; Neurons*/Neurons*/Neurons*/drug effects ; Neurons*/Neurons*/Neurons*/metabolism

  • Source: Cell reports methods [Cell Rep Methods] 2024 Oct 21; Vol. 4 (10), pp. 100881.Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918227360606676 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A computationally supported designer benzodiazepine strategy for public toxicology laboratories.

  • Authors : Ciallella HL; Toxicology Unit, Cuyahoga County Medical Examiner's Office and Regional Forensic Science Laboratory, 11001 Cedar Ave., Cleveland, OH 44106, USA.; Taruvinga DT

Subjects: Benzodiazepines*/Benzodiazepines*/Benzodiazepines*/analysis ; Designer Drugs*/Designer Drugs*/Designer Drugs*/analysis ; Substance Abuse Detection*/Substance Abuse Detection*/Substance Abuse Detection*/methods

  • Source: Journal of analytical toxicology [J Anal Toxicol] 2024 Oct 28; Vol. 48 (8), pp. 541-549.Publisher: Oxford University Press Country of Publication: England NLM ID: 7705085 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The surge of bromazolam-related fatalities replacing other novel designer benzodiazepines-related fatalities in San Francisco.

  • Authors : Rodda LN; Office of the Chief Medical Examiner, San Francisco, CA, USA.; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA, USA.

Subjects: Drug Overdose*/Drug Overdose*/Drug Overdose*/mortality ; Designer Drugs*/Designer Drugs*/Designer Drugs*/poisoning ; Benzodiazepines*/Benzodiazepines*/Benzodiazepines*/poisoning

  • Source: Addiction (Abingdon, England) [Addiction] 2024 Aug; Vol. 119 (8), pp. 1487-1490. Date of Electronic Publication: 2024 Apr 28.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9304118 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Pharmacological insights emerging from the characterization of a large collection of synthetic cannabinoid receptor agonists designer drugs.

  • Authors : Gioé-Gallo C; Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Universidade de Santiago de Compostela, Santiago de Compostela 15782, Spain; Departamento de Química Orgánica, Facultad de Farmacia, Universidade de Santiago de Compostela, Santiago de Compostela 15782, Spain.

Subjects: Designer Drugs*/Designer Drugs*/Designer Drugs*/toxicity ; Cannabis*; Animals

  • Source: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Aug; Vol. 164, pp. 114934. Date of Electronic Publication: 2023 May 24.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Designer Receptor Exclusively Activated by Designer Drug (DREADD)-Mediated Activation of the Periaqueductal Gray Restores Nociceptive Descending Inhibition After Traumatic Brain Injury in Rats.

  • Authors : Irvine KA; Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California, USA.; Anesthesiology Service Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA.

Subjects: Periaqueductal Gray*/Periaqueductal Gray*/Periaqueductal Gray*/drug effects ; Periaqueductal Gray*/Periaqueductal Gray*/Periaqueductal Gray*/metabolism ; Brain Injuries, Traumatic*/Brain Injuries, Traumatic*/Brain Injuries, Traumatic*/metabolism

  • Source: Journal of neurotrauma [J Neurotrauma] 2024 Jul; Vol. 41 (13-14), pp. e1761-e1779. Date of Electronic Publication: 2024 Apr 30.Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 8811626 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Metabolic characterization of 25X-NBOH and 25X-NBOMe phenethylamines based on UHPLC-Q-Exactive Orbitrap MS in human liver microsomes.

  • Authors : Xiang J; Department of Forensic Toxicology, Academy of Forensic Science, Shanghai Key Laboratory of Forensic Medicine, Shanghai Forensic Science Platform, Key Laboratory of Forensic Sciences, Ministry of Justice, Shanghai 200063, PR China; College of Forensic Medicine, Hebei Medical University, Hebei Key Laboratory of Forensic Medicine, Collaborative Innovation Center of Forensic Medical Molecular Identification, Research Unit of Digestive Tract Microecosystem Pharmacology and Toxicology, Chinese Academy of Medical Sciences, Shijiazhuang 050017, Hebei Province, PR China.

Subjects: Designer Drugs*/Designer Drugs*/Designer Drugs*/metabolism ; Hallucinogens*; Humans

  • Source: Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2024 May 15; Vol. 242, pp. 116020. Date of Electronic Publication: 2024 Feb 07.Publisher: Elsevier Science Country of Publication: England NLM ID: 8309336 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Chemogenetic Signaling in Space and Time: Considerations for Designing Neuroscience Experiments Using DREADDs.

  • Authors : Clark PJ; Department of Neurobiology and Anatomy, College of Medicine, Drexel University, Philadelphia, PA, USA.; Brodnik ZD

Subjects: Neurosciences*/Neurosciences*/Neurosciences*/methods ; Designer Drugs*/Designer Drugs*/Designer Drugs*/pharmacology; Animals

  • Source: The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry [Neuroscientist] 2024 Jun; Vol. 30 (3), pp. 328-346. Date of Electronic Publication: 2022 Nov Publisher: Sage Publications Country of Publication: United States NLM ID: 9504819 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  56,864 results for ""DESIGNER drugs""